2020
All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors
Gordon K, Manhapra A, Crystal S, Dziura J, Edelman E, Skanderson M, Kerns R, Justice A, Tate J, Becker W. All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors. Drug And Alcohol Dependence 2020, 216: 108291. PMID: 33011662, PMCID: PMC7644145, DOI: 10.1016/j.drugalcdep.2020.108291.Peer-Reviewed Original ResearchConceptsMorphine equivalent daily doseCause mortalityLong-term opioid therapyTime-updated Cox regressionStrong dose-response relationshipUnnatural deathsEquivalent daily doseDose-response relationshipOpioid doseOpioid therapyUninfected patientsOpioid useDaily doseCox regressionMortality outcomesTherapy doseHigh doseMale veteransOverdose fatalitiesOverdose mortalityPLWHMortalityHIVPatientsDose
2009
Simple Exercise Recovery Index for Sympathetic Overactivity Is Linked to Insulin Resistance
YECKEL CW, GULANSKI B, ZGORSKI ML, DZIURA J, PARISH R, SHERWIN RS. Simple Exercise Recovery Index for Sympathetic Overactivity Is Linked to Insulin Resistance. Medicine & Science In Sports & Exercise 2009, 41: 505-515. PMID: 19204601, DOI: 10.1249/mss.0b013e31818afa2f.Peer-Reviewed Original ResearchConceptsOral glucose tolerance testSympathetic overactivityInsulin resistancePercent body fatExercise recoveryHR recoveryParasympathetic functionBody fatWhole-body insulin sensitivity indexEffective clinical meansHomeostasis assessment modelRecovery indexMeal-induced thermogenesisGlucose tolerance testInsulin sensitivity indexNovel functional indicesParasympathetic dysfunctionCause mortalitySympathetic dysfunctionSympathetic functionObese adolescentsTolerance testInitial plateau phaseIntense exerciseParasympathetic control